The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mirani, M.
Right arrow Articles by Kino, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mirani, M.
Right arrow Articles by Kino, T.
The Journal of Immunology, 2002, 169: 6361-6368.
Copyright © 2002 by The American Association of Immunologists

HIV-1 Protein Vpr Suppresses IL-12 Production from Human Monocytes by Enhancing Glucocorticoid Action: Potential Implications of Vpr Coactivator Activity for the Innate and Cellular Immunity Deficits Observed in HIV-1 Infection

Marco Mirani*, Ilia Elenkov{ddagger}, Simona Volpi{dagger}, Naoki Hiroi*, George P. Chrousos* and Tomoshige Kino1,*

* Pediatric and Reproductive Endocrinology Branch and {dagger} Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892; and {ddagger} Division of Rheumatology, Immunology, and Allergy, Georgetown University, Washington, DC 20007

The HIV-1 protein Vpr has glucocorticoid receptor coactivator activity, potently increasing the sensitivity of glucocorticoid target tissues to cortisol. Patients with AIDS and normal cortisol secretion have manifestations compatible with glucocorticoid hypersensitivity of the immune system, such as suppression of innate and cellular immunities. The latter can be explained by glucocorticoid-induced inhibition of cytokine networks regulating innate and Th1-driven cellular immunity. We demonstrated that extracellularly administered Vpr protein dose-dependently potentiated glucocorticoid-induced suppression of both mRNA expression and secretion of IL-12 subunit p35 and IL-12 holo-protein, but not IL-12 subunit p40 or IL-10, by human monocytes/macrophages stimulated with LPS or heat-killed, formalin-fixed Staphylococcus aureus (Cowan strain 1). This effect was inhibited by the glucocorticoid receptor antagonist RU 486. Also, Vpr changed the expression of an additional five glucocorticoid-responsive genes in the same direction as dexamethasone and was active in potentiating the trans-activation, but not the trans-repression, properties of the glucocorticoid receptor on nuclear factor {kappa}B- or activating protein 1-regulated simple promoters. Thus, extracellular Vpr enhances the suppressive actions of the ligand-activated glucocorticoid receptor on IL-12 secretion by human monocytes/macrophages. Through this effect, Vpr may contribute to the suppression of innate and cellular immunities of HIV-1-infected individuals and AIDS patients.




This article has been cited by other articles:


Home page
 FASEB J.Home page
N. Nader, G. P. Chrousos, and T. Kino
Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications
FASEB J, May 1, 2009; 23(5): 1572 - 1583.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
W. Ma, S. Mishra, N. Gajanayaka, J. B. Angel, and A. Kumar
HIV-1 Nef Inhibits Lipopolysaccharide-induced IL-12p40 Expression by Inhibiting JNK-activated NF{kappa}B in Human Monocytic Cells
J. Biol. Chem., March 20, 2009; 284(12): 7578 - 7587.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
B. Majumder, N. J. Venkatachari, S. O'Leary, and V. Ayyavoo
Infection with Vpr-Positive Human Immunodeficiency Virus Type 1 Impairs NK Cell Function Indirectly through Cytokine Dysregulation of Infected Target Cells
J. Virol., July 15, 2008; 82(14): 7189 - 7200.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
S. Shrivastav, T. Kino, T. Cunningham, T. Ichijo, U. Schubert, P. Heinklein, G. P. Chrousos, and J. B. Kopp
Human Immunodeficiency Virus (HIV)-1 Viral Protein R Suppresses Transcriptional Activity of Peroxisome Proliferator-Activated Receptor {gamma} and Inhibits Adipocyte Differentiation: Implications for HIV-Associated Lipodystrophy
Mol. Endocrinol., February 1, 2008; 22(2): 234 - 247.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
H. Ideura, K. Hiromura, N. Hiramatsu, T. Shigehara, S. Takeuchi, M. Tomioka, T. Sakairi, S. Yamashita, A. Maeshima, Y. Kaneko, et al.
Angiotensin II provokes podocyte injury in murine model of HIV-associated nephropathy
Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1214 - F1221.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
D. H. M. L. P. Navarathna, K. W. Nickerson, G. E. Duhamel, T. R. Jerrels, and T. M. Petro
Exogenous Farnesol Interferes with the Normal Progression of Cytokine Expression during Candidiasis in a Mouse Model
Infect. Immun., August 1, 2007; 75(8): 4006 - 4011.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
N. Hiramatsu, K. Hiromura, T. Shigehara, T. Kuroiwa, H. Ideura, N. Sakurai, S. Takeuchi, M. Tomioka, H. Ikeuchi, Y. Kaneko, et al.
Angiotensin II Type 1 Receptor Blockade Inhibits the Development and Progression of HIV-Associated Nephropathy in a Mouse Model
J. Am. Soc. Nephrol., February 1, 2007; 18(2): 515 - 527.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
A. Balasubramanyam, H. Mersmann, F. Jahoor, T. M. Phillips, R. V. Sekhar, U. Schubert, B. Brar, D. Iyer, E. O. Smith, H. Takahashi, et al.
Effects of transgenic expression of HIV-1 Vpr on lipid and energy metabolism in mice
Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E40 - E48.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
C. W. Wieland, S. Florquin, J. M. Pater, S. Weijer, and T. van der Poll
CD4+ Cells Play a Limited Role in Murine Lung Infection with Mycobacterium kansasii
Am. J. Respir. Cell Mol. Biol., February 1, 2006; 34(2): 167 - 173.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Ichijo, A. Voutetakis, A. P. Cotrim, N. Bhattachryya, M. Fujii, G. P. Chrousos, and T. Kino
The Smad6-Histone Deacetylase 3 Complex Silences the Transcriptional Activity of the Glucocorticoid Receptor: POTENTIAL CLINICAL IMPLICATIONS
J. Biol. Chem., December 23, 2005; 280(51): 42067 - 42077.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
B. Majumder, M. L. Janket, E. A. Schafer, K. Schaubert, X.-L. Huang, J. Kan-Mitchell, C. R. Rinaldo Jr., and V. Ayyavoo
Human Immunodeficiency Virus Type 1 Vpr Impairs Dendritic Cell Maturation and T-Cell Activation: Implications for Viral Immune Escape
J. Virol., July 1, 2005; 79(13): 7990 - 8003.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
T. Kino, A. Gragerov, A. Valentin, M. Tsopanomihalou, G. Ilyina-Gragerova, R. Erwin-Cohen, G. P. Chrousos, and G. N. Pavlakis
Vpr Protein of Human Immunodeficiency Virus Type 1 Binds to 14-3-3 Proteins and Facilitates Complex Formation with Cdc25C: Implications for Cell Cycle Arrest
J. Virol., March 1, 2005; 79(5): 2780 - 2787.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
K. Muthumani, D. S. Hwang, A. Y. Choo, S. Mayilvahanan, N. S. Dayes, K. P. Thieu, and D. B. Weiner
HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro
Int. Immunol., February 1, 2005; 17(2): 103 - 116.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
T. Kino, M. U. De Martino, E. Charmandari, T. Ichijo, T. Outas, and G. P. Chrousos
HIV-1 Accessory Protein Vpr Inhibits the Effect of Insulin on the Foxo Subfamily of Forkhead Transcription Factors by Interfering With Their Binding to 14-3-3 Proteins: Potential Clinical Implications Regarding the Insulin Resistance of HIV-1-Infected Patients
Diabetes, January 1, 2005; 54(1): 23 - 31.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
C. A. Newton, T. Lu, S. J. Nazian, I. Perkins, H. Friedman, and T. W. Klein
The THC-induced suppression of Th1 polarization in response to Legionella pneumophila infection is not mediated by increases in corticosterone and PGE2
J. Leukoc. Biol., October 1, 2004; 76(4): 854 - 861.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.